Share issue in IDEX
The board of IDEX ASA (“IDEX”) has resolved issue of combined 3,150,000 new shares in the company, to Cenkos Securities plc (“Cenkos”) and Charles Street Securities Ltd. (“Charles Street”).
Cenkos and Charles Street earned fees amounting to 4.0 and 2.0 per cent respectively, on the private placement to funds managed by Woodford Investment Management LLP (“Woodford funds”) resolved by the extraordinary general meeting in IDEX on 29 April 2015. The fees, amounting to NOK 11,865,000 and NOK 5,932,500 respectively, were payable in shares or cash, as determined by the agents, as stated in the listing prospectus dated 7 May 2015. Both Cenkos and Charles Street have notified IDEX that they wish to receive the commission in the form of shares in IDEX.
2,100,000 shares are issued to Cenkos and 1,050,000 shares are issued to Charles Street at the same subscription price as the shares issued to the Woodford funds, NOK 5.65 per share. 1/3 of the shares shall be held for a minimum period of 12 months from the date of issuance, 1/3 of the shares shall be held for a minimum period of 6 months following the date of issuance, and the remaining 1/3 of the shares shall be free from restrictions.
The shares were issued under the authorization to the board to issue shares, resolved by the annual general meeting on 12 May 2015. The board chose to apply the existing shareholders’ waiver of preemptive right to subscribe for shares because the instant share issue settles a payable debt and is an integral part of the transaction with the Woodford funds.
Following the placement, the company’s share capital is NOK 70,883,912.25 divided into 472,559,416 registered shares each with a nominal value of NOK 0.15.
6 July 2015
IDEX ASA
Web: www.idexbiometrics.com
Twitter: http://www.twitter.com/idexasa
LinkedIn: http://www.linkedin.com/company/idex-asa
Contacts
Erling Svela, VP Finance, +47 4062 1040, erling.svela(at)idexbiometrics.com
About IDEX
IDEX ASA specialises in fingerprint imaging and recognition technology. The company has a strong patent portfolio consisting of 25 patent families including more than 215 granted patents, as well as cross licenses with Apple. IDEX has a highly competitive product road map including swipe sensors, touch sensors with disruptive cost positions, and a unique in-glass solution. The company is currently in the process of commercialising the products.
IDEX’s addressable market represents a multi-billion unit opportunity, centered on three core markets: Mobile as the core focus, ID & smart cards medium term and the Internet of Things in the future. IDEX has seen a substantial increase in interest from global OEMs in the last quarters, and is positioned as of three independent players with the relevant IP to capture market share.
IDEX ASA (ticker IDEX) is a Norwegian public company listed at the Oslo Børs (Oslo stock exchange). For more information, please visit www.idexbiometrics.com or contact IDEX at mailbox@idexbiometrics.com
–o–
